GLP-1 medications like semaglutide and tirzepatide have transformed how we think about weight loss. They work through three primary mechanisms: appetite suppression, delayed gastric emptying, and improved glucose homeostasis.¹ But as more people experience significant weight loss on these drugs, a less-discussed side effect has come into focus—what happens to your skin.
According to the American Academy of Dermatology, patients on GLP-1s have reported all of these changes: thinning hair, premature skin aging, dry skin from hormonal shifts and reduced food and water intake, slower nail growth and brittleness, and loose skin.²
The story of how GLP-1s affect your skin is more complicated than excess skin sagging after weight loss. There are biological mechanisms happening at the cellular level—some of it damaging, some of it protective. Here's what the science says.
What "Ozempic Face" Actually Is
The term "Ozempic face" was coined by dermatologist Paul Jarrold Frank to describe the facial aging he was seeing in patients on GLP-1 receptor agonists. The effect tends to be more noticeable in people who lose more weight.³
GLP-1s tend to affect specific areas of the face: the cheeks, temples, neck, and the regions around the eyes. The visible result is deeper wrinkles, sagging skin that creates marionette lines, more pronounced nasolabial folds, and jowling. The proportions of the lips, chin, and cheeks can also shift, disrupting overall facial harmony.⁴
These advanced signs of aesthetic aging aren't unique to GLP-1s. The phenomenon has been documented for years in patients who experience massive weight loss through other means—bariatric surgery patients have been shown to appear up to five years older than peers of similar age who haven't lost significant weight.⁵
Plus, stopping the medication doesn't necessarily reverse it. Discontinuing Ozempic may lead to some weight regain, but the fat often doesn't redistribute the way it was before. Because of this, even after regaining weight, signs of facial aging may persist.⁶
Why It Happens: The Biology Beneath the Skin
Part of skin changes and aesthetic aging observed with GLP-1 use is structural. Your skin sits on top of fat and muscle, which give your face its shape and tension. When that scaffolding shrinks, the skin above it has nothing to support it. In one study, participants taking Ozempic showed a 41.8% reduction in the superficial temporal fat pad and a 69.9% reduction in the cheek fat pad.⁷
But beneath the obvious volume loss, several other changes are also happening:
Collagen and elastin loss. Skin quality depends on a dense network of collagen and elastin fibers in the dermis. After massive weight loss, biopsies show that collagen fibers in the reticular dermis are substantially destroyed—losing their characteristic shape and density—and elastic fibers deteriorate significantly, leading to fibrosis throughout the dermis. With this loss, the skin becomes weaker and less resistant to physical stress.⁸
Compromised skin barrier. Studies also show a loss of essential fatty acids, ceramides, and cholesterol that make up the stratum corneum, which compromises your skin's barrier. This shows up as dryness and a lackluster appearance.⁴ Studies on liraglutide have also shown a significant decrease in epidermal thickness.⁹
Loss of protective fat cells. Fat cells aren't just padding. They actively protect against skin aging. They secrete hormones and growth factors associated with skin rejuvenation, influence sebum production and hair follicle activity, support collagen synthesis, and have antioxidant properties that protect skin cells from oxidative damage. Intrinsic aging itself is associated with the gradual loss of fat cells in the subcutaneous region.⁸
Direct cellular effects on dermal stem cells. GLP-1 receptors are present in skin tissue, though their full role is still being understood.⁹ GLP-1 receptor agonists appear to act directly on dermal white adipose tissue (DWAT) and on adipose-derived stem cells (ADSCs). When GLP-1 binds to receptors on ADSCs, it inhibits their proliferation and differentiation, reduces their ability to produce protective factors, and decreases their glucose intake—which lowers ATP production and can trigger apoptosis (cell death). The absence of those protective factors promotes reactive oxygen species (ROS) and causes oxidative damage to fibroblasts, reducing their ability to produce collagen.³
In other words, GLP-1s may accelerate skin aging not just because you're losing weight, but because they're acting directly on the cells that help keep skin youthful.
The Estrogen Connection
One of the most underappreciated effects of GLP-1s on skin runs through estrogen. Dermal white adipose tissue is a major source of estrogen production—particularly important after menopause, when WAT takes over from the ovaries as the body's primary supplier of estrogen.⁸
Estrogen matters enormously for skin. Fibroblasts have estrogen receptors on their surface, and when stimulated, they increase collagen production. Lower estrogen means less collagen synthesis and more activity from metalloproteinase-1, an enzyme that breaks collagen and elastin down. Estrogen deficiency also reduces glycosaminoglycans and hyaluronic acid, both essential for the stratum corneum's ability to hold water.³,⁸
When GLP-1s reduce dermal adipose tissue and inhibit the stem cells that produce estrogen locally, they're effectively removing one of the skin's most important hormonal protectors. For postmenopausal women, this can compound an already accelerated rate of skin thinning.
Nutrient Deficiencies Compound the Problem
GLP-1s suppress appetite, making it harder to get the nutrients your skin needs. Vitamin A supports keratinization and immune function; deficiency is associated with dry, keratotic skin. Vitamin D affects cell growth and skin regeneration. Iron deficiency can cause pallor, glossitis, and brittle nails. Copper deficiency impairs wound healing and contributes to fragile hair and depigmentation.¹
Additionally, protein deficiency is particularly important and particularly common.
How GLP-1s May Support Skin
While the visible effects of GLP-1s on the face can look like accelerated aging, the cellular biology that is affected by GLP-1s may actually be supportive to skin.
Enhanced collagen production. Research suggests GLP-1 receptor signaling may influence fibroblast activity by enhancing collagen production and extracellular matrix turnover, potentially offsetting some of the effects of fat loss on elasticity.¹
Reduction of advanced glycation end products (AGEs). AGEs are damaging compounds that accumulate in skin and accelerate aging—they impair barrier function, obstruct wound healing, increase melanin production, promote fibroblast death, and cross-link with collagen and elastin to stiffen tissue. GLP-1 receptor agonists have been found to reduce AGE levels and the chronic inflammation they drive.³
Improved microcirculation. Studies have shown that GLP-1RAs affect endothelial function in the small blood vessels of skin and subcutaneous tissue, increasing microvascular perfusion. Better blood flow means better oxygen and nutrient delivery which can support skin health, wound healing, and regeneration.³
Improvements in inflammatory skin conditions. Because GLP-1s help manage obesity, insulin resistance, inflammation, and metabolic health, they can improve skin diseases connected to those conditions. Weight loss and better blood sugar management have been shown to improve psoriasis symptoms, and GLP-1s may help patients whose psoriasis doesn't respond well to biologics. Patients with hidradenitis suppurativa have reported fewer flare-ups, less drainage, less pain, and better quality of life on GLP-1s—with the most benefit in patients who also have obesity or type 2 diabetes.²,¹⁰
So GLP-1s appear to do something genuinely paradoxical: they may improve skin at the cellular level (more collagen production, fewer AGEs, better blood flow, less inflammation) while making it look older at the structural level (volume loss, sagging, reduced elasticity). For some people losing significant weight, the structural loss can win out visibly.
What About Cellular Senescence?
If you've been following longevity research, you know that cellular senescence—when cells stop dividing but don't die, accumulating and driving inflammation—is one of the central mechanisms of aging. This has led researchers to explore the impact of GLP-1s on senescence. Here's what the emerging research shows:
GLP-1s have been shown to reduce senescence in blood vessels, kidneys, brain, bones, and the liver.¹¹ They appear to do this by enhancing DNA repair through APE1 expression, modulating the antioxidant defense system, and protecting against oxidative stress-induced senescence.¹¹ They also boost mitochondrial function and quell chronic inflammation—both major drivers of aging.¹²
Unfortunately, their effect on senescence in skin specifically hasn't been directly studied yet. Since skin has GLP receptors, the biology suggests GLP-1s likely have similar effects on skin, but more research is needed to confirm this.
At this stage, data suggests that GLP-1s act as anti-aging agents at the cellular level in multiple tissues, while the visible aging effects in skin are largely a downstream consequence of structural loss from fat and muscle and the cellular effects on dermal adipose tissue and stem cells.
What About Muscle Loss?
Up to 20-50% of weight loss on GLP-1s comes from muscle rather than fat.⁴ This matters for your face too—facial muscle mass contributes to the contour and tone of your features.
The research is conflicting here. Some studies show GLP-1s cause loss of fat-free mass, lean body mass, or skeletal muscle that exceeds fat loss. Others suggest GLP-1s may actually protect muscle and stimulate myogenesis.³,⁸ The dichotomy underscores how much research still needs to be done. What's clear is that without intervention, many people on GLP-1s do experience meaningful muscle loss—and that loss contributes to both how your face looks and how your body functions. Not only does it provide the structure beneath the skin, it also helps regulate metabolism and glucose, therefore maintaining and building muscle while taking a GLP-1 should be top priority.
How to Use GLP-1s and Protect Your Skin
The good news is that most of what drives the negative effects on skin can be mitigated. Here's what the research supports.
Prioritize protein and resistance training
Resistance training is the primary muscle-preserving exercise recommended for people on GLP-1s.¹³ Combined with adequate protein, it's the single most important intervention for preserving lean mass.
On protein: the recommendation is 1.2-1.6 grams per kilogram of adjusted body weight per day. Never go below 0.4-0.5 g/kg/day—that level triggers muscle atrophy. Despite these recommendations, a cross-sectional study of GLP-1 users found only 43% of patients were even hitting the minimum 1.2 g/kg/day, with protein making up just 18-19% of daily energy intake on average.¹³
Distribution matters too. Research suggests roughly 30g of protein at each of three meals produces better overall protein synthesis than a skewed pattern, and observational data in older adults links balanced distribution to greater appendicular lean mass, however there is some conflicting evidence and it appears overall protein intake is what matters most.¹³
Creatine is also worth considering—20g/day for 5-7 days as a loading dose, then 3-5g/day maintenance, increases lean mass and strength when combined with resistance training.¹³
Consider HRT for postmenopausal women
Because GLP-1s reduce estrogen production from dermal adipose tissue, postmenopausal women are particularly vulnerable to compounding skin effects. Clinical trials have consistently shown that postmenopausal women on hormone replacement therapy maintain greater skin thickness, elasticity, and water-holding capacity than nonusers. Without HRT, postmenopausal women lose an average of 2.1% of total collagen per year; with HRT, skin thickness is about 10% greater than in premenopausal women.⁸ The first 18 postmenopausal years are when skin thinning accelerates most, and HRT can counter that. This is a conversation to have with your physician.
Hydrate, supplement, and eat for skin health
Adequate hydration and a diet rich in antioxidants, vitamins, and trace elements supports collagen synthesis and helps mitigate oxidative stress. Copper and zinc aid collagen stabilization and repair. Iron and copper are essential for collagen synthesis and skin health. High-fat and high-sugar diets, on the other hand, drive AGE formation and weaken collagen networks.¹
Collagen peptide supplementation has clinical support—one study found 15g per day of collagen supplementation can reduce body fat in adults over 50 while supporting skin elasticity.¹
Other practical steps: drink plenty of fluids, run a humidifier (cleaned regularly to prevent mold), and consider retinoids—though if your skin is already dry from GLP-1s, retinoids may cause irritation, so introduce them cautiously.
In-office treatments to consider
For people experiencing significant facial aging, dermatologists offer a range of options. Dermal fillers, skin tightening techniques, and surgical interventions can address both volume loss and excess skin.¹⁴
Fat transfers using autologous processed lipoaspirate cells (about 30% of which are ADSCs) show promising results for rejuvenation, texture, and volume restoration, though fat resorption rates make outcomes variable.⁸
Soft tissue fillers can both restore volume and stimulate collagen production, enhancing elasticity.⁸
Laser resurfacing combined with PRP has emerged as an effective pairing for skin rejuvenation. PRP enhances healing by increasing growth factor concentration, improves fat graft survival by stimulating angiogenesis, and enhances dermal elasticity through fibroblast proliferation and collagen production.⁸
The OneSkin GLP Protocol
We developed three products specifically suited to supporting skin resilience, firmness, and hair density during GLP-1 use.
OS-01 FACE MOISTURIZER supports collagen production, firmness, elasticity, and barrier strength. In a double-blind, third-party 12-week clinical study with 22 participants ages 54-65, 96% showed more even tone, radiance, and visible firmness after 12 weeks; barrier resilience increased by 19% after 6 weeks; and 91% showed improved elasticity after 12 weeks (Zonari, A., et al. Journal of Cosmetic Dermatology, 2024).
OS-01 BODY MOISTURIZER supports barrier strength, hydration, and resilience below the neck. In a double-blind, third-party 12-week clinical study with 27 participants ages 62-82, barrier resilience increased by 41%, hydration increased by 38%, and 70% reported visibly smoother texture (Zonari, A., et al. Journal of Cosmetic Dermatology, 2025).
OS-01 HAIR SCALP SERUM supports follicle health and reduces the hair's stress response. CRH, a stress hormone, has been shown to induce senescence in follicle cells, which leads to hair thinning.⁹ OS-01 HAIR has been shown to reduce CRH-induced senescence, which may help mitigate hair's stress response—a particularly relevant mechanism given that GLP-1-related shedding appears to be largely stress-driven. In a 6-month, double-blind, independent, third-party clinical study with 32 participants (23F, 9M) ages 27-55, hair density increased by 40% (shown in 81% of users) and hair thickness increased by 43% (shown in 78% of users) after 6 months; 75% observed visible new hair after 3 months; and 72% reported less visible shedding after 6 months. (Data unpublished, but outlined here).
The Bottom Line
GLP-1 medications represent a real advancement in treating obesity and metabolic disease. They also have real effects on skin, hair, and nails—effects that go beyond simple volume loss and reach into the cellular biology of the skin itself. Some of those effects are likely protective (reduced AGEs, improved blood flow, anti-inflammatory effects, possible anti-senescence activity), while some of those effects result in skin sagging and advanced visible aging (loss of dermal adipose tissue and skin stem cells, reduced estrogen production, accelerated visible aging in those who lose significant weight). They seem to net out differently depending on the GLP-1 medication someone is taking and the degree of fat and muscle loss that they experience. The data suggests that the negative effects are primarily a result of fat and muscle loss, with the degree of those negative effects being correlated with the amount of fat lost, while the positive results stem from the cellular improvements induced by the GLP-1 medication.
What matters is that most of the downsides are mitigable. Resistance training and adequate protein protect the muscle that gives your face and body its structure. HRT, where appropriate, protects the estrogen that protects your skin. Hydration, nutrient-rich eating, and topical support protect the barrier and the cells that keep skin resilient.
You don't have to choose between metabolic health and skin health. You just have to know the right tools to mitigate side effects.
Sources
- https://www.scirp.org/journal/paperinformation?paperid=141648
- https://www.aad.org/public/everyday-care/skin-care-secrets/prevent-skin-problems/glp1-drugs-and-side-effects
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12370548/
- https://onlinelibrary.wiley.com/doi/epdf/10.1002/der2.70003
- https://pubmed.ncbi.nlm.nih.gov/26311559/
- https://isiena.com.mx/fact_check/ozempic.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11427949/
- https://academic.oup.com/asj/article/44/11/NP809/7693294
- https://jcadonline.com/review-glucagon-peptide-1-dermatology/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12110338/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8947838/
- https://www.sciencedirect.com/science/article/abs/pii/S0378512224001233
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12957034/
- https://pubmed.ncbi.nlm.nih.gov/37541662/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11068553/